Nurse Practitioner, Psychiatric/Mental Health · Gonzales, LA
NPI
1972183739
Since 2021
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
13170 Dutchtown Point Ave Apt 1421
Gonzales, LA, 70737
Phone (225) 773-0942
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$640K
1,878 prescriptions
Company payments, 2025
$412
From 5 companies
Medicare prescription drug claims, 2024
In 2024, the drug Tonya G Stelly prescribed most often to Medicare patients was Benztropine Mesylate, with 143 prescriptions and refills. In total Tonya G Stelly wrote 1,878 Medicare prescriptions that cost $640K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-14.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Benztropine Mesylate Generic | 143 | 143 | 21 | $1,436 |
| Divalproex Sodium Generic | 126 | 126 | 17 | $1,562 |
| Buspirone Hcl Generic | 111 | 112 | 15 | $682 |
| Haloperidol Generic | 104 | 104 | 15 | $3,270 |
| Invega Sustenna Paliperidone Palmitate | 101 | 101 | 15 | $299K |
| Trazodone Hcl Generic | 93 | 99 | 21 | $446 |
| Quetiapine Fumarate Generic | 89 | 89 | 14 | $796 |
| Hydroxyzine Pamoate Generic | 83 | 84 | 13 | $463 |
| Olanzapine Generic | 77 | 81 | 11 | $857 |
| Escitalopram Oxalate Generic | 75 | 75 | Under 11 | $376 |
| Risperidone Generic | 72 | 72 | 12 | $442 |
| Divalproex Sodium Er Divalproex Sodium | 54 | 56 | Under 11 | $1,301 |
| Sertraline Hcl Generic | 52 | 56 | Under 11 | $256 |
| Aripiprazole Generic | 52 | 52 | Under 11 | $2,255 |
| Perseris Risperidone | 47 | 47 | Under 11 | $133K |
Brand drugs: 211 claims; generic drugs: 1,667 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tonya G Stelly $412 ($412 in general payments such as food, travel and fees) from 5 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $238.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.